MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with Z

Zuclopenthixol

Zuclopenthixol 2mg tablets

Use with caution

Stability notes for Zuclopenthixol 2mg tablets

Light sensitive medicine. Store in light resistant container. Original packaging may contain desiccant. Manufacturer recommends storing in original container. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This compatibility recommendation is derived from Clopixol 2mg tablets (Lundbeck Ltd).

Suppliers

Clopixol 2mg tablets (Lexon (UK) Ltd)
Clopixol 2mg tablets (Lundbeck Ltd)
Clopixol 2mg tablets (Sigma Pharmaceuticals Plc)

Zuclopenthixol 10mg tablets

Use with caution

Stability notes for Zuclopenthixol 10mg tablets

Original packaging may contain desiccant. Manufacturer recommends storing in original container. Anecdotal reports of use in MCAs (low quality evidence)

Provenance

This compatibility recommendation is derived from Clopixol 10mg tablets (Lundbeck Ltd).

Suppliers (4) of Zuclopenthixol 10mg tablets
Clopixol 10mg tablets (Drugsrus Ltd)
Clopixol 10mg tablets (Lundbeck Ltd)
Clopixol 10mg tablets (Pilsco Ltd)
Clopixol 10mg tablets (Sigma Pharmaceuticals Plc)

Zuclopenthixol 25mg tablets

Use with caution

Stability notes for Zuclopenthixol 25mg tablets

Original packaging may contain desiccant. Manufacturer recommends storing in original container. Anecdotal reports of use in MCAs (low quality evidence)

Provenance

This compatibility recommendation is derived from Clopixol 25mg tablets (Lundbeck Ltd).

Suppliers

Clopixol 25mg tablets (Drugsrus Ltd)
Clopixol 25mg tablets (Lundbeck Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.